Sign In
Buy MYO
$1.10
+0.0400 (+3.77%)
At Close: Jun 03, 2026
Myomo, Inc. (MYO) CEO Paul Gudonis on Q3 2021 Results - Earnings Call Transcript
06:59pm, Wednesday, 10'th Nov 2021
Myomo, Inc. (MYO) CEO Paul Gudonis on Q3 2021 Results - Earnings Call Transcript
Myomo, Inc. Announces Agreements for Exercise of 2020 Investor Warrants
09:15am, Friday, 15'th Oct 2021
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo, Inc. to Present at Fall Harvest - Best Ideas from the Buy-Side on October 5th
04:30pm, Tuesday, 28'th Sep 2021
BOSTON, MA / ACCESSWIRE / September 28, 2021 / Myomo, Inc. (NYSE American:MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering f
Myomo Inc.: Fundamentals And Technicals Are Aligned For This Unique Microcap
11:53pm, Thursday, 16'th Sep 2021
Myomo Inc.: Fundamentals And Technicals Are Aligned For This Unique Microcap
Myomo, Inc. Announces Participation in Three September Investment Conferences
04:30pm, Thursday, 02'nd Sep 2021
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American:MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologic
MYO Stock Price Increases Over 32% Intraday: Why It Happened
01:40pm, Tuesday, 10'th Aug 2021
The stock price of Myomo Inc (NYSEAMERICAN: MYO) increased by over 32% during intraday trading. This is why it happened.
Myomo' (MYO) CEO Paul Gudonis on Q2 2021 Results - Earnings Call Transcript
09:15pm, Monday, 09'th Aug 2021
Myomo' (MYO) CEO Paul Gudonis on Q2 2021 Results - Earnings Call Transcript
Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates
07:59pm, Monday, 09'th Aug 2021
Myomo, Inc. (MYO) delivered earnings and revenue surprises of 25.81% and 51.86%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Myomo, Inc. (MYO) Moves 5.5% Higher: Will This Strength Last?
06:46am, Friday, 11'th Jun 2021
Myomo, Inc. (MYO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Why I Didn't Buy Myomo: Dilution And Cash Burn
11:46pm, Wednesday, 09'th Jun 2021
Why I Didn't Buy Myomo: Dilution And Cash Burn
Myomo: Ridiculously Cheap Medtech
03:03am, Thursday, 13'th May 2021
Myomo has a revolutionary product that allows people with paralyzed arms to use them once more.
Myomo, Inc. (MYO) CEO Paul Gudonis on Q1 2021 Results - Earnings Call Transcript
05:39am, Sunday, 09'th May 2021
Myomo, Inc. (MYO) CEO Paul Gudonis on Q1 2021 Results - Earnings Call Transcript
Myomo, Inc. (MYO) Reports Q1 Loss, Tops Revenue Estimates
07:56pm, Wednesday, 05'th May 2021
Myomo, Inc. (MYO) delivered earnings and revenue surprises of 17.39% and 31.24%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Myomo Participates in Ground-breaking Brain-computer Interface Trial
08:05am, Thursday, 01'st Apr 2021
BOSTON--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurologi
Myomo, A High Risk And High Potential Investment At The Right Time
02:26pm, Wednesday, 24'th Mar 2021
Myomo develops, manufactures, and sells a wearable medical device for stroke patients that lost control or strength in their arms. Myomo's recent quarter and future growth prospects look bright in par
